Related Experiment Video
Updated: Mar 14, 2026

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
[Annual progress in critical care of pulmonary medicine 2025]
1Senior Department of Pulmonary and Critical Care Medicine, Chinese PLA General Hospital, Beijing 100091, China.
Abstract:
This review systematically summarizes the annual research advances in the field of critical care of pulmonary, with a focus on pulmonary and critical care medicine (PCCM) worldwide from October 2024 to September 2025. This review focuses on severe pulmonary infections and their associated complications, such as sepsis and acute respiratory distress syndrome (ARDS), with an emphasis on early screening, diagnosis, and precision treatment. Key areas covered include rapid diagnosis of severe infections, early warning systems, dynamic assessment, personalized management of respiratory critical illnesses, and the clinical application of big data and artificial intelligence. The aim of this review is to provide valuable insights and practical guidance for healthcare professionals and researchers engaged in clinical practice and scientific research in PCCM.
More Related Videos
08:22The Application of Point-of-Care Ultrasonography (POCUS) in the Management of Acute Respiratory Distress Syndrome (ARDS) in the Intensive Care Unit
Published on: December 12, 2025
04:53Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
Published on: October 18, 2024
Related Concept Videos
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia III: Complications and Assessment
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...